Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 33 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
321 21.0 months colon cancer (metastatic) 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 8/2005
Treatment Details: Patients: This Phase II study involved 63 patients with metatstatic colorectal cancer with unresectable liver metastases. Thirty-seven patients had prior chemotherapy, and their data are an
 
322 21.0 months rectal cancer (metastatic) 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 8/2005
Treatment Details: Patients: This Phase II study involved 63 patients with metatstatic colorectal cancer with unresectable liver metastases. Thirty-seven patients had prior chemotherapy, and their data are an
 
323 21.0 months Newly diagnosed GBM Biologic therapy
Chemotherapy
Radiation
Surgery
Hopital Neurologique, Lyon France 1/2001
Treatment Details: Patients: This Phase II study involved eleven patients ten patients with glioblastoma and one patient with an anaplastic astrocytoma. Treatment: The treatment consisted of surgery (or b
 
324 21.0 months Advanced colorectal cancer 4 Chemotherapy
Kyushu University Japan 12/2010
Treatment Details: Patients: This phase II study involved 40 patients with untreated advanced colorectal cancer. The median age of the patients was 63 years and 29 were males. Treatment: Patients were tr
 
325 21.0 months Metastatic, hormone-refractory prostate cancer 2 Biologic therapy
Chemotherapy
University of Pisa Italy 8/2009
Treatment Details: Patients: This phase 2 study involved 28 patients with metastatic, hormone-refractory prostate cancer. Most had received chemotherapy previously. The median age was 74.5, ranging from 54 t
 
326 21.0 months SMLC 5 Chemotherapy
Radiation
Stanford University United States 6/2009
Treatment Details: Patients: This study involved 68 patients with limited-stage small-cell lung cancer. The median age was 63, with a range of 39-86, and 44% were male. Treatment: Patients were given a
 
327 21.0 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
Sarah Cannon Research Institute United States 8/2009
Treatment Details: Patients: This study involved 41 women with HER2-overexpressing metastatic breast cancer. The median age was 57 years (range 27-79). Treatment: The women in this study were given a com
 
328 20.9 months Recurrent ovarian cancer 5 Chemotherapy
Cedars-Sinai Medical Center United States 2/2012
Treatment Details: Patients: This study involved women with recurrent ovarian cancer who were separated into two separate treatment groups. Group A had 53 patients with a median age of 59 years. Group B had
 
329 20.9 months Metastatic urothelial cancer 5 Chemotherapy
Massachusetts General Hospital Cancer Center United States 3/2012
Treatment Details: Patients: This study involved women with HER2-negative locally advanced or metastatic breast cancer who were divided into two separate treatment groups. Group A had 115 patients with an av
 
330 20.9 months Advanced colorectal cancer 3 Chemotherapy
Kurume University Hospital Japan 2/2013
Treatment Details: Patients: This phase 2 study involved 45 advanced or recurrent colorectal cancer patients who were not previously treated. The average patient age was 62 years and 27 were male. Treatme
 
Page 33 of 187  | Previous Page  | Next Page